Literature DB >> 10533638

Massive pleural effusions in cryptococcal meningitis.

C M Wong1, K H Lim, C K Liam.   

Abstract

Cryptococcal infection uncommonly presents with pulmonary manifestations and even more rarely so as massive bilateral effusions. Pleural involvement is usually associated with underlying pulmonary parenchymal lesions and is unusual while on antifungal therapy. We report a patient with cryptococcal meningitis who, while on intravenous 5-flucytosine and amphotericin B, developed life-threatening bilateral massive pleural effusions with evidence of spontaneous resolution, consistent with prior hypothesis of antigenic stimulation as the cause of pleural involvement.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10533638      PMCID: PMC1741239          DOI: 10.1136/pgmj.75.883.297

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  4 in total

Review 1.  Cryptococcus neoformans empyema in a patient receiving ibrutinib for diffuse large B-cell lymphoma and a review of the literature.

Authors:  Christopher David Swan; Thomas Gottlieb
Journal:  BMJ Case Rep       Date:  2018-07-18

2.  Pleural involvement in cryptococcal infection.

Authors:  Vasiliki E Georgakopoulou; Christos Damaskos; Pagona Sklapani; Nikolaos Trakas; Aikaterini Gkoufa
Journal:  World J Clin Cases       Date:  2022-06-06       Impact factor: 1.534

3.  Penetration of amphotericin B lipid formulations into pleural effusion.

Authors:  Stefan Weiler; Rosa Bellmann-Weiler; Michael Joannidis; Romuald Bellmann
Journal:  Antimicrob Agents Chemother       Date:  2007-09-04       Impact factor: 5.191

Review 4.  Pleural fluid secondary to pulmonary cryptococcal infection: a case report and review of the literature.

Authors:  Yuan Zhang; Sean X Zhang; Julie Trivedi; Adam D Toll; Julie Brahmer; Russell Hales; Sarah Bonerigo; Mingying Zeng; Huiping Li; Rex C Yung
Journal:  BMC Infect Dis       Date:  2019-08-12       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.